1.1 Introduction
Sickle cell disease is a hereditary blood disorder characterized by the presence of abnormal hemoglobin known as hemoglobin S, which causes red blood cells to assume a sickle or crescent shape under conditions of low oxygen tension (World Health Organization, 2020). The disease is recognized as one of the most prevalent genetic disorders globally, with a particularly high burden in sub-Saharan Africa, especially in Nigeria, where a significant proportion of the population carries the sickle cell trait (Akinyanju et al., 2017). The management of sickle cell disease is complex and requires a multidisciplinary approach that integrates clinical care with accurate and timely laboratory support. Laboratory services play a fundamental role in the diagnosis, monitoring, and management of the disease. Techniques such as hemoglobin electrophoresis, high-performance liquid chromatography, and complete blood count analysis are essential for confirming diagnosis, assessing disease severity, and detecting complications early (Piel et al., 2017).
As a prelude to other parts of this study, this chapter will discuss the background upon which this study was initiated, the statement of problems that led to this study, the Aim and Objectives of the study. Others are significance of the study, scope of work, research hypothesis and questions, limitation of the study and definition of terms.
1.2 Background of Study
Sickle cell disease has remained a significant global health challenge, particularly in sub-Saharan Africa, where its prevalence continues to place a heavy burden on healthcare systems. According to World Health Organization, sickle cell disease is one of the most common inherited blood disorders worldwide, with millions of people affected and a high rate of morbidity and mortality, especially in low- and middle-income countries. The condition is characterized by abnormal hemoglobin structure, which leads to the distortion of red blood cells into a sickle shape, resulting in chronic anemia, painful vaso-occlusive crises, and progressive organ damage. The burden of the disease is particularly pronounced in Nigeria, which accounts for a substantial proportion of global sickle cell cases.
Akinyanju et al. (2017) reported that Nigeria has the highest number of individuals living with sickle cell disease, with an estimated 150,000 children born annually with the condition. The management of sickle cell disease is multifaceted, involving preventive, diagnostic, and therapeutic interventions. Among these, laboratory services are playing a central role in ensuring accurate diagnosis, monitoring disease progression, and guiding treatment decisions. According to Piel et al. (2017), laboratory diagnosis remains the cornerstone of sickle cell disease management, as clinical symptoms alone are insufficient for definitive diagnosis. Techniques such as hemoglobin electrophoresis, high-performance liquid chromatography, and genetic testing are essential for identifying the presence of hemoglobin S and differentiating it from other hemoglobinopathies.
Federal Ministry of Health Nigeria (2019) asserted that effective laboratory services are indispensable for the routine monitoring of patients with sickle cell disease. Regular laboratory investigations, including complete blood count, liver and kidney function tests, and infection screening, are necessary for detecting complications early and initiating timely interventions. These services are also crucial in guiding therapeutic measures such as blood transfusion, antibiotic therapy, and the use of disease-modifying drugs like hydroxyurea. Without reliable laboratory support, clinical management is becoming largely empirical, which may compromise patient outcomes.
Olatunya et al. (2015) stated that inadequate laboratory infrastructure, shortage of skilled personnel, and inconsistent quality control measures are major barriers to the delivery of accurate and timely diagnostic services. Furthermore, Okpala (2016) affirmed that poor integration of laboratory services into the overall healthcare delivery system is contributing to inefficiencies in patient management. In many cases, there is limited collaboration between laboratory scientists and clinicians, leading to delays in diagnosis and treatment. Patients often experience prolonged waiting times for test results, which is increasing the risk of complications and hospital admissions.
The establishment of specialized institutions such as the Sickle Cell Foundation Nigeria represents a significant step toward addressing these challenges. The foundation is providing comprehensive care for individuals living with sickle cell disease, including diagnostic, therapeutic, and counseling services. It is also playing a vital role in promoting awareness, supporting research, and improving access to quality laboratory services. Through its initiatives, the foundation is helping to bridge gaps in care and enhance the overall management of the disease. This study is set against the backdrop of the ongoing efforts to improve sickle cell disease management in Nigeria, with particular focus on the Sickle Cell Foundation Nigeria.
1.3 Statement of Problems
Sickle cell disease remains a major public health concern in Nigeria, where the burden of the disorder is among the highest globally. Despite advancements in diagnostic and management strategies, many patients continue to experience frequent complications, reduced quality of life, and high mortality rates. Laboratory services are widely recognized as a critical component in the effective management of sickle cell disease, as they provide essential support for early diagnosis, routine monitoring, and timely intervention. However, in many healthcare settings, including specialized centers such as the Sickle Cell Foundation Nigeria, the extent to which laboratory services effectively contribute to improved patient outcomes is still a subject of concern.
Investigation revealed that the reliability and accessibility of laboratory investigations remain inconsistent, particularly in resource-constrained environments. Diagnostic tools such as hemoglobin electrophoresis and full blood count testing are essential for confirming sickle cell disease and monitoring its progression, yet challenges such as inadequate equipment, irregular power supply, and shortage of skilled laboratory personnel often limit their effectiveness (WHO, 2020).
On the other hand, even when laboratory services are available, their integration into comprehensive patient management frameworks is often inadequate. There is limited coordination between laboratory scientists and clinicians, which is reducing the efficiency of care delivery. Patients may undergo repeated tests without proper documentation or follow-up, leading to increased healthcare costs and unnecessary stress. In addition, the level of awareness among patients regarding the importance of routine laboratory monitoring is still relatively low, which is contributing to poor adherence to medical advice and irregular clinic visits (Akinyanju et al., 2017).
Furthermore, there is insufficient data management and record-keeping systems within laboratory units, which is affecting research, monitoring, and evaluation of treatment outcomes. The absence of reliable data is making it difficult to assess the true impact of laboratory services on patient management and to design evidence-based interventions. It is against this backdrop that this study seeks to examine the role of laboratory services in managing sickle cell disease.
1.4 Aim and Objectives of Study
The aim of this study is to assess the role of laboratory services in managing sickle cell disease at the Sickle Cell Foundation Nigeria.
The specific objectives of the study are:
- To examine the types of laboratory services available for sickle cell management
- To evaluate the effectiveness of laboratory diagnostic methods in patient care
- To identify challenges affecting laboratory service delivery
- To assess the level of integration between laboratory services and clinical management
- To determine the impact of laboratory services on treatment outcomes in sickle cell patients
1.5 Research Questions
The study came up with research questions so as to be able to ascertain the above stated objectives. The specific research questions for the study are stated below as follows:
- What types of laboratory services are available for the management of sickle cell disease at the Sickle Cell Foundation Nigeria?
- How effective are the laboratory diagnostic methods used in patient care?
- What challenges are affecting laboratory service delivery?
- What is the level of integration between laboratory services and clinical management?
- What impact do laboratory services have on treatment outcomes in sickle cell patients?
1.6 Research Hypotheses
In order to pursue the objective of this study, the following generalized statements have been designed to guide and aids in obtaining the result for the experiment to be conducted. For this work, the null hypothesis will be represented with H0 while the alternative hypothesis will be represented with hypothesis H1.
Hypothesis One
- H0: Laboratory services have no significant effect on the management of sickle cell disease
- H1: Laboratory services have a significant effect on the management of sickle cell disease
Hypothesis Two
- H0: There is no significant relationship between laboratory diagnostic methods and patient care outcomes
- H1: There is a significant relationship between laboratory diagnostic methods and patient care outcomes
Hypothesis Three
- H0: Challenges in laboratory service delivery do not significantly affect sickle cell disease management
- H1: Challenges in laboratory service delivery significantly affect sickle cell disease management
Hypothesis Four
- H0: There is no significant integration between laboratory services and clinical management
- H1: There is significant integration between laboratory services and clinical management
Hypothesis Five
- H0: Laboratory services do not significantly influence treatment outcomes in sickle cell patients
- H1: Laboratory services significantly influence treatment outcomes in sickle cell patients
1.7 Significance of Study
The outcome of this research will provide documented evidence on how laboratory services contribute to the diagnosis and monitoring of sickle cell disease at the Sickle Cell Foundation Nigeria. Also, healthcare providers will benefit as the study will present factual data on laboratory service efficiency in patient management.
Furthermore, the findings will support the development of strategies aimed at improving laboratory infrastructure and service efficiency in sickle cell management.
Lastly, researchers will use the findings as a reliable reference for further academic and clinical studies.
1.8 Scope and Limitations of the Study
The scope of the research is focused on assessing the role of laboratory services in the management of sickle cell disease within Sickle Cell Foundation Nigeria located in Lagos State. It covers laboratory diagnostic procedures, service delivery processes, and their impact on patient management.
The study was limited by restricted access to some laboratory records and operational data within the Sickle Cell Foundation Nigeria in Lagos State. There was also limited time available for extensive data collection and analysis.
1.9 Definition of Terms
Sickle Cell Disease:
Sickle Cell Disease is a hereditary blood disorder characterized by abnormal hemoglobin that causes red blood cells to become sickle-shaped, leading to anemia and other complications (World Health Organization, 2020).
Laboratory Services:
Laboratory Services refer to medical diagnostic procedures carried out in a laboratory setting to detect, monitor, and manage diseases through analysis of blood and other body samples (Federal Ministry of Health Nigeria, 2019).
Hemoglobin Electrophoresis:
Hemoglobin Electrophoresis is a laboratory technique used to identify different types of hemoglobin in the blood, particularly for diagnosing sickle cell disease (Piel et al., 2017).
Diagnosis:
Diagnosis is the process of identifying a disease or condition through evaluation of symptoms and laboratory test results.
Patient Management:
Patient Management refers to the comprehensive approach to treating and monitoring patients to improve health outcomes.
Clinical Integration:
Clinical Integration is the coordination between laboratory services and healthcare providers to ensure effective patient care.
…